Collegium Pharmaceutical
COLL
COLL
238 hedge funds and large institutions have $1.06B invested in Collegium Pharmaceutical in 2024 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 71 increasing their positions, 92 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
238
Holders Change
-10
Holders Change %
-4.03%
% of All Funds
3.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
36
Increased
71
Reduced
92
Closed
45
Calls
$707K
Puts
$277K
Net Calls
+$430K
Net Calls Change
-$1.38M
Top Buyers
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
$67.3M |
| 2 |
Invesco
Atlanta,
Georgia
|
$50.9M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
$8.34M |
| 4 |
Citadel Advisors
Miami,
Florida
|
$10.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
$5.74M |
Top Sellers
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
$61.4M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
$0 |
| 3 |
Goldman Sachs
New York
|
$6.29M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
$87.9K |
| 5 |
JPMorgan Chase & Co
New York
|
$2.37M |
